LAQ824

LAQ824

CAT N°: 16427
Price:

From 74.00 62.90

LAQ824 is a hydroxamate-based inhibitor of histone deacetylases (HDACs) with an IC50 value of 30 nM.{26872,18374} It inhibits the growth of colon, breast, prostate, and non-small cell lung cancer cell lines at concentrations of less than 1 µM.{26872,18481} LAQ824 augments the actions of fludarabine (Item No. 14128) and imatinib mesylate (Item No. 13139) in human leukemia cells.{26871,26870} Through its effects on HDACs, LAQ824 induces acetylation of histones, ?-tubulin, and heat shock protein 90 (Hsp90).{26870,16189} Acetylation of Hsp90 blocks its chaperone function, resulting in changes in levels of several client proteins, including estrogen receptor-?, Hsp72, and Raf-1.{16189,26868}

We also advise you